122 filings
Page 5 of 7
CORRESP
dtxeisvh mwc
18 May 21
Correspondence with SEC
12:00am
8-K
zexm1 qt0v9yl8
17 May 21
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
4:15pm
10-Q
qbxz2kiswhh4
17 May 21
Quarterly report
4:10pm
8-K
ef7cl7bin 12
12 May 21
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:21pm
424B4
5aq4un6zj9
10 May 21
Prospectus supplement with pricing info
5:06pm
EFFECT
geir1 1ckgw
7 May 21
Notice of effectiveness
12:15am
S-1MEF
4i5wp25s1j1
6 May 21
Registration of additional securities for an S-1
7:26pm
UPLOAD
p1q8t
4 May 21
Letter from SEC
12:00am
CORRESP
5cfo89s
4 May 21
Correspondence with SEC
12:00am
CORRESP
sshmq3h4cpfjdnn2co
4 May 21
Correspondence with SEC
12:00am
UPLOAD
v1vfevu2mkogayh6
20 Apr 21
Letter from SEC
12:00am
DRS
epd02ila x4tx3fzq
13 Apr 21
Draft registration statement
12:00am
8-K
p3pqel r7mj3r9
2 Apr 21
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
2:00pm
8-K
9vht er04br7lpt5hws
25 Mar 21
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
4:15pm
10-K
rdgjoxrl8b 2jb5
25 Mar 21
Annual report
4:15pm
8-K
e2cklt
19 Feb 21
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults
4:15pm
8-K
fzp6s6vkpuf elyl9
15 Dec 20
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:05pm